Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Utah Medical Products Q2 EPS $0.35 Down From $0.94 YoY, Sales $8.79M Down From $11.85M YoY

Author: Benzinga Newsdesk | July 28, 2020 09:04am
Utah Medical Products (NASDAQ:UTMD) reported quarterly earnings of $0.35 per share. This is a 62.77 percent decrease over earnings of $0.94 per share from the same period last year. The company reported $8.79 million in sales this quarter. This is a 25.80 percent decrease over sales of $11.85 million the same period last year.

Posted In: UTMD

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist